chevron_leftBack
As of 13 June 2026, Rainmed Medical Ltd. has a market cap of $43.09M USD, ranking #31621 globally and #6116 in China.
It ranks #4766 in the Technology sector, and #358 in the Scientific & Technical Instruments industry.
Key Stats
Market Cap
$43.09MUSD
337.73M HKD
Enterprise Value
$24.94MUSD
195.44M HKD
Revenue (TTM)
$2.72MUSD
21.34M HKD
EBITDA (TTM)
-$8.06MUSD
-63.15M HKD
Net Income (TTM)
-$10.95MUSD
-85.78M HKD
EBITDA Margin
-296%
PS Ratio
15.8
PB Ratio
0.8
Company Profile
Country (HQ)
Sector
Technology
Industry
Scientific & Technical Instruments
Employees
214
Founded
2014
Website
rainmed.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.4% | -11% | -15% | -11% | -18% | 32% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
2297
潤邁德醫療有限公司 Shs
ISIN: KYG7360A1094
Shares Out.:
Shares Outstanding:
1.401B1
Shares Float:
1.222B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.2400 HKD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Rainmed Medical Ltd.
Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of coronary artery ischemia severity based on coronary angiography images; and caIMR System, including FlashAngio caIMR System and FlashPressure caIMR pressure transducer, which is a less-invasive index of microcirculatory resistance measurement product for the treatment of microcirculatory lesions. Rainmed Medical Limited was founded in 2014 and is headquartered in Suzhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 302132
|
$26.46B
61K%
179.27B CNY
|
51.7
|
|
SHE: 002028
|
$22.73B
53K%
154.03B CNY
|
47.6
|
|
SHE: 000725
|
$22.01B
51K%
149.16B CNY
|
24.6
|
|
SHE: 300604
|
$16.28B
38K%
110.29B CNY
|
70.9
|
|
SSE: 688361
|
$9.69B
22K%
65.69B CNY
|
11624.6
|
|
SHE: 002414
|
$9.05B
21K%
61.33B CNY
|
63.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TSE: 6857
|
$134.83B
313K%
21.58T JPY
|
58.0
|
|
TSE: 6861
|
$111.81B
259K%
17.9T JPY
|
40.2
|
|
NYSE: EMR
|
$76.75B
178K%
|
33.9
|
|
NYSE: KEYS
|
$57.53B
133K%
|
60.2
|
|
|
K
XETRA: 1KT
|
$56.48B
131K%
48.57B EUR
|
60.0
|
|
EPA: LR
|
$44.68B
104K%
38.66B EUR
|
31.4
|
chevron_leftBack